Knowles Revenue Jumps 8 Percent in Q2

Knowles (NYSE:KN) reported strong Q2 2025 results, with GAAP revenue of $145.9 million, up 7.9% year-over-year and exceeding analyst estimates by $6.15 million, alongside non-GAAP EPS of $0.24 which also beat expectations. A key highlight was the significant 70.7% year-over-year surge in adjusted free cash flow to $39.6 million, driven by robust demand and increased order activity in its Precision Devices segment. Management provided an optimistic outlook, forecasting continued sequential and year-over-year growth for the remainder of 2025, with Q3 revenue guidance of $144 million to $154 million and non-GAAP EPS of $0.29 to $0.33, signaling sustained operational momentum and strong cash generation.

Analysis

Knowles Corporation (KN) reported a strong second quarter for fiscal 2025, exceeding analyst expectations on both revenue and earnings. The company posted GAAP revenue of $145.9 million, a 7.9% year-over-year increase that surpassed consensus estimates by $6.15 million. Non-GAAP EPS came in at $0.24, beating the forecast of $0.23. The standout metric was the 70.7% year-over-year surge in adjusted free cash flow to $39.6 million, underscoring significant operational efficiency and cash generation, which in turn funded $30 million in share repurchases. This performance was driven by broad-based strength in its high-value Precision Devices segment, evidenced by a robust book-to-bill ratio exceeding 1.15, signaling strong future demand from medtech and defense markets. While non-GAAP gross margins held steady at 44.2%, the GAAP gross margin saw a slight year-over-year contraction to 41.5% from 42.8%. However, management's forward guidance projects confidence, with a Q3 revenue forecast of $144 million to $154 million—implying 10.2% YoY growth at the midpoint—and an expectation for sequential margin improvement, suggesting continued positive momentum into the second half of the year.

Key Decisions for Investors

• The combination of a top and bottom-line beat, a 70.7% surge in adjusted free cash flow, and guidance for accelerating growth in Q3 supports a constructive outlook on the stock.
• Investors should closely monitor gross margin performance in the coming quarters to verify management's ability to deliver on its forecast for sequential improvement, as this is a key factor for validating the long-term profitability thesis.
• The book-to-bill ratio of over 1.15 in the Precision Devices segment and the aggressive share repurchase program are critical indicators of sustained demand and management confidence, respectively.